Robust results, TLT margins improved profitability.

Similar documents
Techno Electric & Engineering Limited

Mold-Tek Packaging Limited

Performance beat on all fronts

Jamna Auto Industries

Institutional Equities

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Colgate-Palmolive (India)

Gillette India. Institutional Equities. 1QFY18 Result Update

Initiating Coverage. Uflex Ltd.

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

Century Plyboards (I) Ltd

Indian Oil Corporation

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

EBITDA 5,076 3, , EBITDA

Dalmia Bharat Enterprises

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL

Punjab National Bank

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY

Amber Enterprises India Ltd

Century Plyboards (I) Ltd

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Bata India. Institutional Equities. 1QFY19 Result Update BUY

Indian Oil Corporation

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN

Institutional Equities

Institutional Equities

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%

Punjab National Bank

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Mahindra & Mahindra Ltd.

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Kalpataru Power. Rating: Target price: EPS: Rating CMP. Target BUY. Rs Rs.256

Repco Home Finance Ltd.

Mahindra & Mahindra Ltd.

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Repco Home Finance Ltd.

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

Hindustan Media Ventures

EBITDA 6,223 6,511 (4.4) 5, EBITDA

CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

Visaka Industries Ltd

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL

BUY. Robust quarter with clear growth visibility DILIP BUILDCON. Target Price: Rs 610. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

Simplex Infrastructures

CMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630

Skipper Ltd. February 13, Towering high. CMP INR 153 Target INR 184 Result Update - BUY. Company Background. Investment Rationale

Skipper Ltd. May 17, Towering high. CMP INR 205 Target INR 238 Result Update - BUY. Company Background. Investment Rationale

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

Institutional Equities

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA

Ahluwalia Contracts (India)

TV Today Network BUY. Performance Update. CMP Target Price `315 `385. 2QFY2017 Result Update Media. Historical share price chart.

CMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

ITC. Rating: Target price: EPS: Relative better visibility despite the smoke, Maintain BUY CMP. Target. Rating. Rs.389. Buy. Rs.

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

Cummins India Ltd Bloomberg Code: KKC IN

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

Adani Ports & SEZ Rating: Target price: EPS:

Fineotex Chemical Ltd

Procter & Gamble Hygiene & Health Care

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE

CMP* (Rs) 203 Upside/ (Downside) (%) 23. Market Cap. (Rs bn) 116 Free Float (%) 61 Shares O/S (mn) 572

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

Bloomberg Code: ATA IN

All the more bullish, TP upgraded

Key estimate revision. Year FY14 23,28,609 3,48,027 1,40, FY15E 25,74,029 3,94,133 1,69,

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

Change EPS. (Rs) FY

Titan Company BUY. Back to Value Zone Validate Rating Upgrade. Institutional Equity Research. November 05, Target Price Rs428.

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely

Dabur India. Institutional Equities. 1QFY19 Result Update

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Initiating Coverage. Vaibhav Global Ltd. (VGL) BUY Back On Track Huge Potential Ahead. 1 P a g e

Transcription:

Power Transmission Equipment Result Update Skipper Ltd BUY Robust results, TLT margins improved profitability. Institutional Research Nifty: 8,4; Sensex: 26,553 CMP (Rs) 153 Target (Rs) 17 Key Stock Data BSE Code 538562 NSE Code SKIPPER Bloomberg Code SKIPPERIN Shares o/s mn (FVRs 2) 12.3 Market Cap (Rsbn) 16. 52-Week High / Low 2 / 93 3-M Daily Avg. Vol. 45,63 Relative Performance 1m 3m 12m SKIPPER 5.1 (8.3) 64.5 NIFTY.9 (5.7) (3.5) Sensex 1.1 (5.5) (4.8) Shareholding Pattern Sep15 Jun15 Mar15 Promoter 72.4 72.4 72.4 FII... DII... Others 27.6 27.6 27.6 Amber Singhania amber.singhania@amsec.in +91 22 4343 5296 Skipper Limited (Skipper); reported healthy results with Adjusted Profit of Rs 129 mn up 67% yoy and 28.8% qoq, came in lower than our estimate of 169mn mainly owing to higher depreciation and tax rate. The EBITDA margin increased by 16bp yoy to 12.2%, led by engineering products segment. The order book stands robust at Rs 22bn (2x FY15 sales), and over 2bn worth of projects under tendering. We believe, on one hand, post restructuring its engineering division is all set to capture the benefits arising from strong macro demand in TLT; both domestic as well as globally, on the other hand its strategy to become a pan India player in PVC pipes and fittings is unfolding well with the new capacities coming on-stream in time and at a low cost. Management guided a higher growth in export revenues in TLT whereas it plans to double the revenue every year in PVC segment on a low base. We estimate a 54% CAGR growth in PAT during FY15-17E. Given the strong order book of Rs22 bn, high and improving EBITDA margins, expansion in PVC segment, and excellent macro environment in power T&D space; we remain positive on the business. We maintain our BUY rating with a TP of Rs17, based on 12x PER of FY17E EPS. reported strong results with EBITDA margin of 12.2%: Revenue grew robust at 32.1% yoy and 48% qoq, due to strong performance in both Engineering and PVC segments. The strong order book led to a 31% yoy growth in Engineering segment revenue, whereas PVC segment revenue grew by 184% yoy on low base. Blended EBITDA margin has improved by 16bp yoy on the back of better margins in engineering products segment. Engineering product segment EBIT margin improved 394bp yoy, owing to better product mix and discontinuation of steel pipes business. Adjusted PAT came in higher at Rs 129mn registering a growth of 67% yoy. The Adjusted PAT is excluding the exceptional income of Rs 181mn on account of currency hedging contracts. Order backlog of Rs 22bn, in provides healthy visibility: Skipper closed with an Oder Backlog of 22bn (2x FY15 revenue) provides strong revenue visibility of over next two years. Skipper has also submitted bids for projects worth more than Rs 2bn, and is expected to see strong inflow in 2HFY16 both from domestic as well as international clients. The current order book includes 45% export orders, 45% PGCIL, and balance from others. PVC products capacity expansion on track: The company is on track for its massive expansion plans in PVC segments from 1, tons to 4, tons in FY16. It has already commenced its Greenfield plant in Ahmedabad during Q1FY16 with a capacity of 1, tons. It has also expanded capacity at its existing plant in Kolkata to 15, tons. Further two new plants one in North and other in Guwahati will be operational in Q3FY16 and 4th plant in Hyderabad in expected to commence operations in Q4FY16. Positive Outlook with rich Valuations: We estimate the revenue and PAT CAGR of 22.2% and 54% during FY15-17E. Return ratios to improve in FY17E with ROCE at 32.2% and ROE at 33.4%. Given the positively placed business model to capture the high growth of TLT segment backed by public spending, increasing export orders, significant improvement in EBITDAM due to restructuring of operations, benefits of backwards integration, 4x expansion in PVC segment, strong return ratios, robust growth, improving EBITDAM and young management team; we believe SKIPPER has a strong business prospects. We maintain our BUY rating and a TP of Rs17 based on 12x PER of FY17E EPS. At CMP the stock is trading at 15.7x FY16E and 1.8x FY17E. Exhibit 1: Key Financials Exhibit 2: Key Ratios Y/E Mar FY13 FY14 FY15 FY16E FY17E Y/E Mar FY13 FY14 FY15 FY16E FY17E Sales 9,3 1,415 12,72 15,21 18,979 EBITDAM 9.5 1.6 13.6 15.3 15.9 yoy 21.5 15.7 22. 19.7 24.8 NPM 2.1 2.6 4.8 6.6 7.6 EBITDA 853 1,12 1,726 2,331 3,8 PER (x) 79.7 58.2 17.6 15.7 1.8 yoy 36.9 29.3 56.6 35.1 29.1 P/BV (x) 7.2 6.8 5.2 4.1 3.2 Adjusted PAT 187 269 612 998 1,45 EV/Sales (x) 2.1 1.9 1.5 1.3 1. yoy 89.1 43.8 231.4 63. 45.3 EV/ EBITDA (x) 22.3 18. 11. 8.2 6.4 Equity 97 12 12 12 12 RoACE 13. 14.5 21.7 27.9 32.2 EPS 1.9 2.6 6. 9.8 14.2 RoANW 1.1 12.3 33.3 29.2 33.4 Refer Disclosures & Disclaimer at the end of the report. Our reports are available on Bloomberg ASNM <GO>, ThomsonReuters, Factset and Capital IQ November 4, 215

Exhibit 3: Skipper Ltd: 2Q FY16 quarterly results Y/E March yoy qoq 1HFY15 1HFY16 yoy Net Sales 2,649 3,227 4,995 2,344 3,436 29.7 46.6 4,481 5,78 29. Other Operational Income - 1 5 22 63 85 Total Sales 2,649 3,227 4,999 2,367 3,499 32.1 47.9 4,481 5,866 3.9 Stock Adjustment (71) (276) 1,128 (74) (197) 175.9 (72.1) (66) (91) 48.8 Cons. of Raw Materials 1,853 2,58 2,489 2,164 2,486 34.2 14.9 3,553 4,651 3.9 Employee Cost 89 93 87 12 124 38.3 21.2 161 226 4.3 Other Expenditure 481 427 68 451 657 36.6 45.6 82 1,18 38.1 Total Expenditure 2,352 2,753 4,312 2,13 3,7 3.5 52.5 3,911 5,84 3. EBITDA 296 474 687 353 429 44.6 21.3 57 782 37.1 Add: Other Income 1 7 1 6 26 2,816.3 324.1 9 32 263.7 Interest 129 173 154 147 114 (11.4) (22.4) 256 262 2.3 Depreciation 51 52 63 59 124 144.7 11.2 15 182 73.9 Excp. Item 42 - - - 181 (56.8) - 42 181 (56.8) Profit Before Tax 538 256 471 153 398 (26.) 159.4 639 552 (13.6) Provision for Taxation 185 86 168 53 161 (13.) 22.2 22 214 (2.7) PAT 353 171 33 1 237 (32.8) 136.6 419 337 (19.4) Adj Net Profit 77 171 33 1 129 67. 28.8 143 226 58.1 Equity Capital (FV `1) 12 12 12 12 12 12 12 Basic EPS (` ) 3.4 1.7 3. 1. 2.3 4.1 3.3 Adjusted EPS (In ` ).8 1.7 3. 1. 1.3 1.4 2.2 EBITDA 11.2 14.7 13.7 14.9 12.2 16bp (269bp) 12.7 13.3 6bp PAT 2.9 5.3 6.1 4.2 3.7 75bp (56bp) 3.2 3.8 65bp Tax / PBT 34.4 33.4 35.7 34.7 4.4 34.5 38.8 Raw Mat. / Net Sales 67.3 69.2 72.4 61.7 65.4 65.8 63.9 Exhibit 4: Skipper Ltd: 2Q FY16 Segmental finance Y/E March yoy qoq 1HFY15 1HFY16 yoy% Segment Revenue Engineering Products 2446 2899 4413 1951 3196 3.7 63.8 435 5147 27.6 PVC products 93 187 434 333 264 184.1 (2.8) 276 596 115.7 Infrastructure Projects 11 141 152 83 39 (64.1) (52.4) 169 122 (27.7) Total Segment Revenue 2649 3227 4999 2367 3499 32.1 47.9 4481 5866 31 Segment Results Engineering Products 233 39 97 295 43 84.8 45.8 449 725 61.4 PVC products 17 19 55 4 32 84.4 (19.9) 29 72 151.8 Infrastructure Projects 28 53 13 19 5 (82.7) (74.5) 45 24 (45.9) Total 279 462 137 355 467 67.7 31.8 523 822 57 Less: Interest (Net) 129 173 154 147 114 (11.1) (22.4) 255 262 2.4 Other Unallocable Exp. -388 32 414 54 71 (118.2) 31. -371 124 (133.5) Profit Before Tax 538 256 47 153 283 (47.5) 84.1 639 436 (31.7) - - Capital Employed - - Engineering Products 7179 7289 658 66 7711 7.4 16.8 7179 7711 7.4 PVC products 294 31 459 375 53 7.9 34.1 294 53 7.9 Infrastructure Projects 25 196 189 214 281 37. 31.6 25 281 37. Total Segment Cap. Emp. 7679 7787 675 7189 8495 1.6 18.2 7679 8495 11 EBIT Margin Engineering Products 9.5 13.5 22. 15.1 13.5 394bp (166bp) 11.1 14.1 295bp PVC products 18.8 1. 12.8 12.1 12.2 (661bp) 14bp 1.4 12.1 174bp Infrastructure Projects 25.8 37.4 8.2 23.4 12.5 (1334bp) (186bp) 26.5 19.9 (666bp) Total EBIT Margin 1.5 14.3 2.8 15. 13.4 284bp (163bp) 11.7 14. 234bp Please refer important Disclosures and Disclaimer at the end of the report. April 11, 211

Exhibit 5: Quarterly Revenue Trend Exhibit 6: Quarterly revenue breakdown 6 5 4 3 2 1 35.6 1565 1.4 2237 3.1 23 Sales 26.2 437 17.1 18.4 1832 2649 4.3 3227 16. 4995 28. 2344 Sales Growth (yoy, %) (RHS) 29.7 3436 45 4 35 3 25 2 15 1 5-5 1% 9% 8% 7% 6% 5% 4% 3% 2% 1% % 3QFY13 4QFY13 Engineering Products PVC products Infrastructure Projects Exhibit 7: Quarterly EBIDTA Trend Exhibit 8: Quarterly PAT Trend 8 14.5 7 6 5 4 3 2 1 226 11. 11. 247 252 8.8 377 15. 274 11.2 296 14.7 13.8 15.1 474 687 353 12.5 429 16. 14. 12. 1. 8. 6. 4. 2.. 35 3 25 2 15 2.7 1 5 42 3.4 75 1.9 44 2.5 18 3.6 66 2.9 77 5.3 171 6.1 33 4.3 1 6.9 237 8. 7. 6. 5. 4. 3. 2. 1.. EBITDA EBITDA Margin (RHS) Adj. PAT PAT Margin (RHS) Exhibit 9: Quarterly Engineering Products trend Exhibit 1: Quarterly PVC products trend 5 45 4 35 3 25 2 15 1 5 22. 15.3 15.1 13.6 13.5 13.5 9.9 1.4 9.5 8. 7. 5.7 254 3244 1365 292 2121 3872 1589 2446 2899 4413 1951 3196 3QFY13 4QFY13 Engineering Products EBIT Margin Exhibit 11: Quarterly Infrastructure Products trend 25. 2. 15. 1. 5.. 5 45 4 35 3 25 2 15 1 5 61.1 146 3QFY13 14.2 138 4QFY13 4.9 179 9.4 1.5 7.8 6.1 98 137 273 184 18.8 12.8 1. 12.1 12.2 93 187 434 333 PVC products EBIT Margin Exhibit 12: PGCIL & Exports constitutes 49% & 51% of total order book 264 7. 6. 5. 4. 3. 2. 1.. 18 16 14 12 1 8 6 4 2 58.3 3QFY13 29 17.8 4QFY13 32 37.4 2 23.7 22.8 47 41 48.9 162 27.8 25.8 59 11 37.4 141 8.2 152 23.4 83 12.5 39 7. 6. 5. 4. 3. 2. 1.. Export Order, 45% Others, 1% PGCIL, 45% PGCIL Export Order Others Infrastructure Projects EBIT Margin Source: AMSEC Research November 4, 215 3

Financials (Consolidated) Profit & Loss Account Cash Flow Statement Particulars FY13 FY14 FY15 FY16E FY17E Particulars FY13 FY14 FY15 FY16E FY17E Net sales 9,3 1,415 12,72 15,21 18,979 PBT 278 367 1,366 1,51 2,132 Other operating inco - - - - - Non-cash adjustments 111 13 23 221 239 Consumption of mate 6,829 7,6 8,797 1,343 12,96 Changes in working capital (1,15) (129) 189 (949) (1,178) Staff Expenses 195 274 341 411 512 Interest Paid 464 65 583 69 637 Other operating expe 1,128 1,439 1,838 2,126 2,553 Tax Paid & Other Adj 28 (91) (451) (53) (682) Total Expenditure 8,151 9,313 1,976 12,879 15,971 Cashflow from operation 45 883 1,889 879 1,148 EBITDA 853 1,12 1,726 2,331 3,8 Capital exp. & Advances (574) (315) (34) (315) (3) Depreciation 126 151 22 241 259 Change in investments - - - - Operating profit 727 951 1,56 2,9 2,749 Other investing cashflow 14 21 17 2 2 Other income 14 21 17 2 2 Cashflow from investing (56) (294) (287) (295) (28) EBIT 741 973 1,523 2,11 2,769 Issue of equity 27 5 () - - Interest 464 65 583 69 637 Issue/repay debt 1,5 165 (566) 1 1 Exceptional items - - (426) - - Interest Paid (464) (65) (583) (69) (637) Profit before tax 278 367 1,366 1,51 2,132 Dividends paid (11) (18) (156) (239) (359) Tax 9 98 474 53 682 Other financing cashflow - - - - - Minority interest - - - - - Cashflow from financing 557 (454) (1,35) (748) (896) Reported net profi 187 269 892 998 1,45 Change in cash & cash eq 43 135 298 (165) (27) Adjusted net profit 187 269 612 998 1,45 Opening cash & cash eq 86 128 263 561 396 Share O/s mn 97 12 12 12 12 Closing cash & cash eq 128 263 561 396 369 EPS Rs (adjusted) 1.9 2.6 6. 9.8 14.2 Free cash flow to firm (528) 567 1,586 564 848 ######## ######## ######## ######## ######## Balance Sheet Ratios Particulars FY13 FY14 FY15 FY16E FY17E Particulars FY13 FY14 FY15 FY16E FY17E SOURCES OF FUNDS : PER SHARE Share Capital 97 12 12 12 12 EPS Rs (adjusted) 1.9 2.6 6. 9.8 14.2 Reserves 1,963 2,29 2,936 3,695 4,786 CEPS Rs 3.2 4.1 8.1 12.1 16.7 Minority Interest - - - - - Book Value Rs 21.1 22.6 29.7 37.1 47.8 Total Shareholders 2,61 2,312 3,39 3,797 4,888 VALUATION Non-Current Liabil 2,183 2,534 1,972 1,972 1,972 EV / Net Sales 2.1 1.9 1.5 1.3 1. Long term borrowing 1,986 2,37 1,77 1,77 1,77 EV / EBITDA 22.3 18. 11. 8.2 6.4 Deferred tax liability 181 218 265 265 265 P / E Ratio 79.7 58.2 17.6 15.7 1.8 Other long term liab 16 1 - - - P / BV Ratio 7.2 6.8 5.2 4.1 3.2 Long-term provisions - - - - - GROWTH YOY% Current Liabilities 3,625 3,969 5,627 5,989 6,873 Sales Growth 21.5 15.7 22. 19.7 24.8 Short term borrowing 1,99 1,755 1,724 1,824 1,924 EBITDA Growth 36.9 29.3 56.6 35.1 29.1 Trade payables 1,162 1,563 2,415 2,79 3,38 Net Profit Growth 89.1 43.8 231.4 63. 45.3 Other current liabiliti 461 626 1,277 1,414 1,518 Gross Fixed Asset Growth 17.9 7.3 8.9 7. 6.5 Short term provisions 11 25 21 42 52 PROFITABILITY Total Equity & Liab 7,869 8,815 1,637 11,757 13,733 Gross Profit/ Net sales 18.2 19.7 22.4 3.1 3.1 APPLICATION OF FUNDS : EBITDA / Net Sales 9.5 1.6 13.6 15.3 15.9 Non Current Asset 3,37 3,489 3,578 3,652 3,693 EBIT / Net sales 8.1 9.1 11.9 13.7 14.5 Gross block (Total) 3,675 3,943 4,295 4,595 4,895 NPM / Total income 2.1 2.6 4.8 6.6 7.6 Less : accumulated d 413 558 782 1,24 1,283 Raw Material/Net Sales 75.8 73. 69.3 68. 68. Net block (Total) 3,262 3,385 3,513 3,571 3,612 Int/PBIT 63.8 63.6 38.7 29.1 23.2 Capital work in progr 36 83 35 5 5 RONW 1.1 12.3 33.3 29.2 33.4 Noncurrent investme - - - - - ROCE 13. 14.5 21.7 27.9 32.2 Deferred tax assets - - - - - ROIC 8.8 1.8 13.1 18.9 22.3 Long term loans and - - - - - Tax / PBT 32.6 26.7 5.4 33.5 32. Other non-current as 9 21 31 31 31 TURNOVER Current Assets 4,562 5,326 7,59 8,15 1,4 Net Woking Cycle 124 112 87 95 99 Current investment - - - - - Debtors Velocity (Days) 63 81 18 15 16 Inventories 2,378 2,29 2,282 2,792 3,536 Inventory (Days) 16 9 76 79 81 Sundry debtors 1,549 2,318 3,758 4,375 5,512 Creditors Velocity (Days) 62 75 1 96 96 Cash and bank 128 263 561 396 369 Current Ratio 3.3 2.8 2.6 2.6 2.5 Short loans and adva 57 455 458 542 624 Quick Ratio 1.6 1.6 1.8 1.7 1.7 Others current assets - - - - - LIQUIDITY Total Assets 7,869 8,815 1,637 11,757 13,733 Gross Asset Ratio 2.7 2.7 3.1 3.4 4. - - - - - Total Asset Ratio 1.2 1.2 1.3 1.4 1.5 Net Working Capital* 3,46 3,193 3,785 4,573 5,75 PAYOUT Net Debt-Equity Ratio 2. 1.8 1.1.9.7 Interest Coverage (x) 1.6 1.6 2.6 3.5 4.3 Total Gross Debt* 4,23 4,395 3,829 3,929 4,29 Payout % 6 7 25 24 25 Total Net Debt 4,12 4,132 3,268 3,532 3,66 Dividend % 1 15 13 2 3 Capital Employed* 6,472 6,924 7,132 7,99 9,181 Yield %.1.1.8 1.3.8 November 4, 215 4

Recommendation rationale Sector rating Buy: Potential upside of >+15% (absolute returns) Accumulate: >+5 to +15% Reduce: +5 to -5% Sell: < -5% Not Rated (NR): No investment opinion on the stock Overweight: Underweight: Neutral: The sector is expected to outperform relative to the Sensex. The sector is expected to underperform relative to the Sensex. The sector is expected to perform in line with the Sensex. Disclosures This Report is published by Asian Markets Securities Private Limited (hereinafter referred to as AMSEC ) for private circulation. AMSEC is a registered Stock Broker with National Stock Exchange of India Limited and BSE Limited in cash and derivatives segments. It is also having registration as a Depository Participant with CDSL and as Portfolio Manager. AMSEC is registered Research Analyst under SEBI (Research Analyst) Regulations, 214 having Registration Number as INH1378. AMSEC has other business divisions with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. AMSEC or its associates have not been debarred / suspended by SEBI or any other regulatory authority for accessing / dealing in securities Market. AMSEC, its associates or analyst or his relatives do not hold any financial interest in the subject company. AMSEC or its associates or Analyst do not have any conflict or material conflict of interest at the time of publication of the research report with the subject company. AMSEC or its associates or Analyst or his relatives hold / do not hold beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of this research report. AMSEC or its associates / analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. AMSEC or its associates have not received any compensation or other benefits from the company covered by Analyst or third party in connection with the research report. Analyst has not served as an officer, director or employee of subject company and AMSEC / analyst has not been engaged in market making activity of the subject company. Analyst Certification:I, Amber Singhania the research analysts and authors of this report, hereby certify that the views expressed in this research report accurately reflects my personal views about the subject securities, issuers, products, sectors or industries. It is also certified that no part of the compensation of the analyst(s) was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this research. The analyst(s) principally responsible for the preparation of this research report and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations. 1. Name of the analyst: Amber Singhania 2. Analysts ownership of any stock related to the information contained: Nil 3. AMSEC ownership of any stock related to the information contained: None 4. Broking relationship with company covered: None 5. Investment Banking relationship with company covered: None November 4, 215 5

Disclaimer This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. AMSEC is not soliciting any action based upon it. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any such transaction. In preparing this research, we did not take into account the investment objectives, financial situation and particular needs of the reader. This research has been prepared for the general use of the clients of AMSEC and must not be copied, either in whole or in part, or distributed or redistributed to any other person in any form. If you are not the intended recipient you must not use or disclose the information in this research in any way. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. AMSEC will not treat recipients as customers by virtue of their receiving this report. This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject AMSEC & its group companies to registration or licensing requirements within such jurisdictions. The report is based on the information obtained from sources believed to be reliable, but we do not make any representation or warranty that it is accurate, complete or up-to-date and it should not be relied upon as such. We accept no obligation to correct or update the information or opinions in it. AMSEC or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. AMSEC or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This information is subject to change without any prior notice. AMSEC reserves its absolute discretion and right to make or refrain from making modifications and alterations to this statement from time to time. Nevertheless, AMSEC is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries. Before making an investment decision on the basis of this research, the reader needs to consider, with or without the assistance of an adviser, whether the advice is appropriate in light of their particular investment needs, objectives and financial circumstances. There are risks involved in securities trading. The price of securities can and does fluctuate, and an individual security may even become valueless. International investors are reminded of the additional risks inherent in international investments, such as currency fluctuations and international stock market or economic conditions, which may adversely affect the value of the investment. Opinions expressed are subject to change without any notice. Neither the company nor the director or the employees of AMSEC accept any liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. Here it may be noted that neither AMSEC, nor its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profit that may arise from or in connection with the use of the information contained in this report. Copyright of this document vests exclusively with AMSEC. Our reports are also available on Fact Set and Bloomberg ASNM <GO> 1 / 2 Athena House, Rajnigandha Complex, Gokuldham, Filmcity Road, Goregaon (East), Mumbai 4 63. India Tel: +91 22 4343 5 Fax: +91 22 4343 543 research.amsec@amsec.in, Website: www.amsec.in November 4, 215 6